CHARACTOL-25 200 MG — DIN 02060205
CHARCOAL ACTIVATED : 200 MG · OMEGA LABORATORIES LIMITED · SUSPENSION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CHARACTOL-25?
CHARACTOL-25 200 MG contains CHARCOAL ACTIVATED : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02060205, held by OMEGA LABORATORIES LIMITED, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 29-Jul-2026. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Medicinal Charcoal in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
21 holders have a Canadian DIN containing Medicinal Charcoal, across 29 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| OMEGA LABORATORIES LIMITED | 4 | 3 | CHARAC-25, CHARAC-50, CHARACTOL-25, CHARACTOL-50 | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | ACTIVATED CHARCOAL, WAMPOLE ACTIVATED CHARCOAL | Sourceable in Canada |
| LABORATOIRE LEO DESILETS M.H. INC | 2 | 1 | ACTIVATED CHARCOAL, ACTIVATED CHARCOAL POWDER | Sourceable in Canada |
| BIOCLINIC NATURALS INC. | 1 | 1 | ACTIVATED CHARCOAL CAPSULES | Sourceable in Canada |
| DSE HEALTHCARE SOLUTIONS LLC | 1 | 1 | CHARCO CAPS | Sourceable in Canada |
| EXZELL PHARMA INC | 1 | 1 | ACTIVATED CHARCOAL 260MG | Sourceable in Canada |
| NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | 1 | 1 | ACTIVATED CHARCOAL CAPSULES | Sourceable in Canada |
| PHARMASCIENCE INC | 3 | 0 | CHARCODOTE TFS SUS 200MG/ML, CHARCODOTE-AQUEOUS SUS 200MG/ML | No marketed DIN |
| FRANK W. KERR CHEMICAL COMPANY | 2 | 0 | INSTA CHAR ADULT 50GM/250ML, INSTA CHAR PEDIATRIC 15GM/120ML | No marketed DIN |
| ARKOPHARMA CANADA INC. | 1 | 0 | CHARCOAL | No marketed DIN |
| SOURCE OF LIFE PRODUCTS, DIVISION OF CHEMIMEX ENT | 1 | 0 | PREMIUM ACTIVATED CHARCOAL USP | No marketed DIN |
| VIVA PHARMACEUTICAL INC. | 1 | 0 | NORICOL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | SUSPENSION |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Medicinal Charcoal |
|---|---|
| ATC code | A07BA01 |
| AHFS class | 56:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02060205 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2060205 |
| Brand name | CHARACTOL-25 |
| Generic / active ingredient | CHARCOAL ACTIVATED : 200 MG |
| Market authorization holder | OMEGA LABORATORIES LIMITED |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BA01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A07BA |
| Current status | CANCELLED POST MARKET |
| Status date | 29-Jul-2026 |
| Original market date | 1985-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 29 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02420694 |
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | LABORATOIRE LEO DESILETS M.H. INC | MARKETED | 02236563 |
| ACTIVATED CHARCOAL 260MG | 260 MG | CAPSULE | EXZELL PHARMA INC | MARKETED | 00789674 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | MARKETED | 02504723 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | BIOCLINIC NATURALS INC. | MARKETED | 02537680 |
| CHARAC-25 | 222 MG | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 02056429 |
| CHARAC-50 | 50 G / 225 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 00637955 |
| CHARACTOL-50 | 50 G / 250 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 00649236 |
| CHARCO CAPS | 260 MG | CAPSULE | DSE HEALTHCARE SOLUTIONS LLC | MARKETED | 02423715 |
| WAMPOLE ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02395517 |
2 · Same class — other molecules in ATC A07BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Medicinal Charcoal | ACTIVATED CHARCOAL · ACTIVATED CHARCOAL 260MG · ACTIVATED CHARCOAL CAP 280MG · ACTIVATED CHARCOAL CAPSULES · +20 more | 29 | 10 | Yes |
| Medicinal Charcoal, Combinations | CARBOSYLANE · CHAR-FLO WITH SORBITOL - SUS · FLAT-EEZE | 3 | 0 | Not in Canada |
| Charcoal Preparations | JAMP-ACTIVATED CHARCOAL · JAMP-ACTIVATED CHARCOAL PLUS | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A07B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A07BB | Bismuth Preparations | 55 | 12 |
| A07BC | Attapulgite · Attapulgite, Combinations · Combinations · Kaolin, Combinations · Pectin, Combinations | 20 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.